Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Aquestive Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 37 | 35 | −2 |
| Shares | 14.9M | 14.9M | +11.8K (+0.1%) |
| Value | $13.5M | $17.0M | +$3.57M (+26.5%) |
New holders (8)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 116,272 | $132.6K | 0.00% |
| Kestra Advisory Services, LLC | 86,350 | $98.4K | 0.00% |
| HBK Sorce Advisory LLC | 42,348 | $48.3K | 0.00% |
| Jane Street Group, LLC | 23,430 | $26.7K | 0.00% |
| Squarepoint Ops LLC | 15,542 | $17.7K | 0.00% |
| Virtu Financial LLC | 12,884 | $15.0K | 0.00% |
| UBS Group AG | 3,744 | $4.27K | 0.00% |
| Simplex Trading, LLC | 1,176 | $1.00K | 0.00% |
Sold out (10)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 506,600 | $457.0K |
| Man Group plc | 89,900 | $81.1K |
| Beacon Pointe Advisors, LLC | 60,000 | $54.1K |
| Citadel Advisors LLC | 2,910 | $2.63K |
| Rockefeller Capital Management L.P. | 3,166 | $2.00K |
| First Manhattan Co | 1,000 | $902 |
| Bank of America Corp | 102 | $92 |
| Coppell Advisory Solutions LLC | 37 | $33 |
| Coppell Advisory Solutions Corp. | 37 | $33 |
| IFP Advisors, Inc | 6,500 | – |